Posted by Clinical Lab Products | Mar 27, 2009 | Biochemicals & Chemical Reagents, Cancer, Unknown Origin & Other Cancer Types |
BioMosaics Inc, a cancer biomarker development company, announced today that its monoclonal antibody product (clone 1G12) for detection of Glypican-3 (GPC3) has been validated for use as an immunohistochemical test for diagnosis of Hepatocellular Carcinoma (HCC).
Read MorePosted by Clinical Lab Products | Mar 9, 2009 | Miscellaneous |
B-R-A-H-M-S Aktiengesellschaft announces that it has submitted 510(k) file to the FDA to market its patented B-R-A-H-M-S MR-proANP Kryptor Test.
Read MorePosted by Clinical Lab Products | Feb 6, 2009 | Cancer, Miscellaneous |
The world in vitro diagnostic test market won’t be stalled by economic conditions for a variety of reasons, according to Kalorama Information.
Read MorePosted by Clinical Lab Products | Jan 13, 2009 | Miscellaneous |
A new national study has shown that nearly 75% of patients hospitalized for a heart attack had cholesterol levels that would indicate they were not at high risk for a cardiovascular event.
Read MorePosted by Clinical Lab Products | Aug 11, 2008 | Cancer, Miscellaneous |
Prostate cancer diagnosis tends to be delayed and surgical treatment more difficult in obese men than in lean men, according to two recently published studies.
Read More